Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Methylene Blue for the Prevention of Hypotension During Hemodialysis — Stella

Home/Acute Kidney Injury/Methylene Blue for the Prevention of Hypotension During Hemodialysis

View on ClinicalTrials.gov

Recruiting

Back to Acute Kidney Injury trials

Methylene Blue for the Prevention of Hypotension During Hemodialysis

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Brazil

Federal University of São Paulo, São Paulo, São Paulo

Key details

Phase

Safety & dosing

Sponsor

Federal University of São Paulo

Enrollment target

~260 participants

Started

October 2021

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.